Cargando…
Combined Use of Common Fecal and Blood Markers for Detection of Endoscopically Active Inflammatory Bowel Disease
Monitoring of disease activity is essential in patients with inflammatory bowel disease. Although endoscopic remission is the ideal therapeutic goal, noninvasive biomarkers (blood and fecal) are more acceptable to patients and are less costly. We evaluated the performance of combinations of fecal an...
Autores principales: | Mak, Lung-Yi, Tong, Teresa S. M., Cheung, Ka-Shing, Chen, Li-Jia, Lui, Ka-Luen, Lau, Kam-Shing, Leung, Wai K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7145039/ https://www.ncbi.nlm.nih.gov/pubmed/32132451 http://dx.doi.org/10.14309/ctg.0000000000000138 |
Ejemplares similares
-
Risk of gastric cancer development after eradication of Helicobacter pylori
por: Cheung, Ka-Shing, et al.
Publicado: (2018) -
Long-term use of proton-pump inhibitors and risk of gastric cancer: a review of the current evidence
por: Cheung, Ka Shing, et al.
Publicado: (2019) -
Modification of gastric cancer risk associated with proton pump inhibitors by aspirin after Helicobacter pylori eradication
por: Cheung, Ka Shing, et al.
Publicado: (2018) -
Gastrointestinal bleeding in patients on novel oral anticoagulants: Risk, prevention and management
por: Cheung, Ka-Shing, et al.
Publicado: (2017) -
Reply
por: Cheung, Ka Shing, et al.
Publicado: (2021)